E. Fearnhill

发表

The Contribution of Viral Genotype to Plasma Viral Set-Point in HIV Infection

J. Hadfield, D. Pillay, A. Leigh Brown, 2014, PLoS pathogens.

Long-term probability of detecting drug-resistant HIV in treatment-naive patients initiating combination antiretroviral therapy.

Delpech, B. Gazzard, C. Leen, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Transmission of Non-B HIV Subtypes in the United Kingdom Is Increasingly Driven by Large Non-Heterosexual Transmission Clusters

A. Leigh Brown, E. Hodcroft, S. Lycett, 2015, The Journal of infectious diseases.

Edinburgh Research Explorer Transmission of non-B HIV subtypes in the UK is increasingly driven by large non-heterosexual clusters

E. Hodcroft, S. Lycett, E. Fearnhill, 2016 .

Novel HIV-1 Recombinants Spreading across Multiple Risk Groups in the United Kingdom: The Identification and Phylogeography of Circulating Recombinant Form (CRF) 50_A1D

A. Leigh Brown, A. Abecasis, A. Geretti, 2014, PloS one.

Evaluating the extent of potential resistance to pre‐exposure prophylaxis within the UK HIV‐1‐infectious population of men who have sex with men

A. Crook, D. Pillay, A. Phillips, 2012, HIV medicine.

A phylotype-based analysis highlights the role of drug-naive HIV-positive individuals in the transmission of antiretroviral resistance in the UK

O. Gascuel, R. Mourad, D. Dunn, 2015, AIDS.

Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV

B. Gazzard, C. Leen, C. Fraser, 2019, Journal of virus eradication.

An Evolutionary Model-Based Algorithm for Accurate Phylogenetic Breakpoint Mapping and Subtype Prediction in HIV-1

Sergei L. Kosakovsky Pond, David Posada, Michael B. Gravenor, 2009, PLoS Comput. Biol..

Recent trends and patterns in HIV‐1 transmitted drug resistance in the United Kingdom

C. Fraser, D. Pillay, C. Sabin, 2016, HIV medicine.

The Changing Epidemiological Profile of HIV-1 Subtype B Epidemic in Ukraine

O. Pybus, L. du Plessis, N. Faria, 2019, AIDS research and human retroviruses.

Automated analysis of phylogenetic clusters

Samantha Lycett, Manon Ragonnet-Cronin, Stéphane Hué, 2013, BMC Bioinformatics.

Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic Reconstruction

C. Fraser, E. Volz, D. Pillay, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Molecular Phylodynamics of the Heterosexual HIV Epidemic in the United Kingdom

David Dunn, Andrew Rambaut, Esther Fearnhill, 2009, PLoS pathogens.

The Impact of Transmitted Drug-Resistance on Treatment Selection and Outcome of First-Line Highly Active Antiretroviral Therapy (HAART)

B. Gazzard, C. Sabin, A. Phillips, 2009, Journal of acquired immune deficiency syndromes.

Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom

John P. Walsh, Andrew N. Phillips, Steve Kaye, 2007, AIDS.

Transmission Network Parameters Estimated From HIV Sequences for a Nationwide Epidemic

Esther Fearnhill, Gareth J. Hughes, A. Leigh Brown, 2011, The Journal of infectious diseases.

Second-Line Protease Inhibitor-Based Antiretroviral Therapy after Non-Nucleoside Reverse Transcriptase Inhibitor Failure: The Effect of a Nucleoside Backbone

A. Phillips, C. Orkin, L. Waters, 2013, Antiviral therapy.

Intercontinental Dispersal of HIV-1 Subtype B Associated with Transmission among Men Who Have Sex with Men in Japan

O. Pybus, A. Leigh Brown, Y. Takebe, 2014, Journal of Virology.

Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy.

Hannah Green, David Dunn, Deenan Pillay, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Sequences in Kiev: Findings Among Key Populations

C. Morrison, P. Vanhems, A. Kamali, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Phylogenetic analyses reveal HIV-1 infections between men misclassified as heterosexual transmissions

Samantha J Lycett, Manon Ragonnet-Cronin, Stéphane Hué, 2014, AIDS.

The Impact of Different Definitions on the Estimated Rate of Transmitted HIV Drug Resistance in the United Kingdom

D. Pillay, D. Dunn, E. Fearnhill, 2008, Journal of acquired immune deficiency syndromes.

Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades

F. Ceccherini‐Silberstein, R. Kaiser, J. Martinez-Picado, 2015, The Journal of antimicrobial chemotherapy.

Drug‐resistance development differs between HIV‐1‐infected patients failing first‐line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues

F. Ceccherini‐Silberstein, C. Sabin, E. Nicastri, 2013, HIV medicine.

HIV type-1 drug resistance in antiretroviral treatment-naive adults infected with non-B subtype virus in the United Kingdom

D. Pillay, D. Chilton, Linda J Harrison, 2010, Antiviral therapy.

Identification of accessory mutations associated with high-level resistance in HIV-1 reverse transcriptase

Hannah Green, David Dunn, Patricia A Cane, 2007, AIDS.

Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance

C. Leen, C. Fraser, E. Volz, 2018, The Journal of antimicrobial chemotherapy.

Evidence of Self-Sustaining Drug Resistant HIV-1 Lineages Among Untreated Patients in the United Kingdom.

D. Pillay, P. Cane, D. Dunn, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Population Trends in the Prevalence and Patterns of Protease Resistance Related to Exposure to Unboosted and Boosted Protease Inhibitors

D. Pillay, C. Sabin, A. Phillips, 2008, Antiviral therapy.

Positive and Negative drug Selection Pressures on the N348I Connection Domain Mutation: New Insights from in vivo Data

David Dunn, Huw Price, Deenan Pillay, 2010, Antiviral therapy.

The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults

C. Sabin, Linda J Harrison, D. Dunn, 2013, AIDS.

Long-term probability of detecting HIV drug resistance in drug-naïve patients starting currently recommended first-line combination ART.

Esther Fearnhill, Alessandro Cozzi-Lepri, David Dunn, 2008 .

Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study

B. Gazzard, D. Webster, C. Leen, 2013, The Journal of antimicrobial chemotherapy.

Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV‐1 resistance mutation

Andrew L. Kerr, C. Leen, C. Fraser, 2020, HIV medicine.